Literature DB >> 10690612

Role of iron load on fibrogenesis in chronic hepatitis C.

M Casaril1, A M Stanzial, P Tognella, M Pantalena, F Capra, R Colombari, R Corrocher.   

Abstract

BACKGROUND/AIMS: In chronic viral hepatitis, an enhanced iron load is related to lower response to interferon. Furthermore, iron, through the production of oxygen radicals, may stimulate hepatocyte necrosis and the activation of cells responsible for synthesis and deposition of extracellular matrix. We investigated the relationship between iron load, evaluated by serum assays, and liver fibrogenesis in chronic active viral hepatitis.
METHODOLOGY: Serum iron, ferritin, transferrin saturation and serum markers of hepatic fibrogenesis (Laminin and the amino-terminal peptide of procollagen III-NPIIIP-) were assayed in 102 patients (47 females, 55 males, mean age 42.48 years) affected by chronic hepatitis C virus and in 81 healthy controls (47 males, 34 females). In hepatitis C virus patients (studied before alpha-interferon treatment) a semiquantitative score for portal inflammation, necrosis and fibrosis was applied to liver biopsy.
RESULTS: Serum indices of iron load were higher in hepatitis C virus patients than in controls, and were higher in cirrhotic than in chronic hepatitis cases. Ferritin and serum iron were positively correlated with NPIIIP and laminin; moreover cases with ferritin levels over the normal limit for sex and age had higher levels of NPIIIP and laminin than cases with normal or poor iron status.
CONCLUSIONS: Our data suggest that even a mild increase of iron load stimulates hepatic fibrogenesis, probably adding oxygen free radical injury to the damage of viral infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690612

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Hepatic iron quantitation and its relationship with disease measures and histologically assessed iron content.

Authors:  Shabbar Sajjad; Moises Garcia; Ahmed Malik; David H Van Thiel
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

2.  Hemochromatosis gene mutations: prevalence and effects on pegylated-interferon and ribavirin therapy response in chronic hepatitis C in sardinia.

Authors:  Margherita Sini; Orazio Sorbello; Alberto Civolani; Luigi Demelia
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

Review 3.  HCV and oxidative stress in the liver.

Authors:  Alexander V Ivanov; Birke Bartosch; Olga A Smirnova; Maria G Isaguliants; Sergey N Kochetkov
Journal:  Viruses       Date:  2013-01-28       Impact factor: 5.048

4.  Predictive role of acute phase reactants in the response to therapy in patients with chronic hepatitis C virus infection.

Authors:  Ayten Oguz; Ahmet Engin Atay; Adnan Tas; Gulseren Seven; Mehmet Koruk
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.